RenovoRx, Inc.
RNXT· Nasdaq
Released May 13, 2022, after the close
10-Q filed May 13, 2022, 43 days after period end · 0001493152-22-013294
| Metric | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|
| Net Income | -$3.00M | -$1.15M | -$1.05M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
RenovoRx, Inc. · CIK 1574094 · Engraved from SEC EDGAR
ended Mar 31, 2022 · filed May 13, 2022 · 43 d after period end